Creative Biolabs-Immuno-oncology

Anti-CD19 (clone 1G0Z5L9Q7J7J) SynExpress pU-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR916)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD19 (clone 1G0Z5L9Q7J7J). We employs the pGEM (pUC-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Exons Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD19
Clone
1G0Z5L9Q7J7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pUC
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.85
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.